×
Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.
VEGFR2/CD309 anticorps (AA 1057-1061)
VEGFR2
Reactivité: Humain, Souris
WB
Hôte: Lapin
Polyclonal
unconjugated
Détail du produit anti-VEGFR2/CD309 anticorps
(cache)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps
VEGFR2/CD309 (VEGFR2)
(VEGF Receptor 2 (VEGFR2))
Épitope
Tous les épitopes à travers VEGFR2/CD309 Anticorps.
AA 1057-1061
Reactivité
Toutes les réactivités sur VEGFR2/CD309 Anticorps
Humain, Souris
Hôte
Toutes les hôtes sur VEGFR2/CD309 Anticorps
Lapin
Clonalité
Toutes les clonalités sur VEGFR2/CD309 Anticorps
Polyclonal
Conjugué
Tous les conjugués à travers VEGFR2/CD309 Anticorps
Cet anticorp VEGFR2/CD309 est non-conjugé
Application
Tous les applications à travers VEGFR2/CD309 Anticorps.
Western Blotting (WB)
Séquence
P-D-Y-V-R
Specificité
This antibody detects endogenous levels of total VEGFR2 protein.
Réactivité croisée (Details)
Species reactivity (tested):Human, Mouse
Purification
Affinity-chromatography using epitope-specific peptide
Immunogène
Peptide sequence around aa. 1057~1061
Top Product
Discover our top product VEGFR2 Anticorps primaire
Alternatives
(show)
Information d'application
(cache)
Indications d'application
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Stockage
(cache)
Format
Liquid
Concentration
1.0 mg/mL
Buffer
Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation
Avoid repeated freezing and thawing.
Stock
-20 °C
Stockage commentaire
Store (in aliquots) at -20 °C.
Détails sur VEGFR2/CD309
(cache)
Antigène
VEGFR2/CD309 (VEGFR2)
(VEGF Receptor 2 (VEGFR2))
Autre désignation
CD309 / VEGFR-2 / Flk-1 (VEGFR2 Produits )
Synonymes
anticorps CD309, anticorps FLK1, anticorps VEGFR, anticorps VEGFR2, anticorps 6130401C07, anticorps Flk-1, anticorps Flk1, anticorps Krd-1, anticorps Ly73, anticorps VEGFR-2, anticorps sVEGFR-2, anticorps Vegfr-2, anticorps FLK-1, anticorps flk-1, anticorps vegfr-2, anticorps KDR, anticorps FLK/KDR, anticorps flk1, anticorps flk1b, anticorps kdrb, anticorps si:busm1-205d10.1, anticorps si:ch211-254j6.1, anticorps si:ch211-278f21.4, anticorps wu:fc31a09, anticorps fk52c05, anticorps flk, anticorps kdr, anticorps kdra, anticorps vegfr2, anticorps vegfr4, anticorps vegr2, anticorps wu:fk52c05, anticorps kinase insert domain receptor, anticorps kinase insert domain protein receptor, anticorps vascular endothelial growth factor receptor kdr-like, anticorps kinase insert domain receptor (a type III receptor tyrosine kinase), anticorps kinase insert domain receptor like, anticorps KDR, anticorps Kdr, anticorps LOC100136647, anticorps kdr, anticorps kdrl
Sujet
Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.Synonyms: FLK1, KDR, Kinase NYK, Kinase insert domain receptor, Protein-tyrosine kinase receptor Flk-1, VEGF Receptor 2, VEGFR2, Vascular endothelial growth factor receptor 2
Poids moléculaire
210/230 kDa
ID gène
3791
NCBI Accession
NP_002244
UniProt
P35968
Pathways
Signalisation RTK , Glycosaminoglycan Metabolic Process , Signaling Events mediated by VEGFR1 and VEGFR2 , Growth Factor Binding , Regulation of long-term Neuronal Synaptic Plasticity , VEGF Signaling
Vus récemment
(cache)